A fluorescence antibody test with monoclonal antibodies was used to determine the subgroup (A or B) of respiratory syncytial virus from infants hospitalized in Caen, France, over eight consecutive epidemics from 1982 to 1990 . From 1982 out of 90 frozen nasal slides were classified as subgroup A strain-s and 63 (70%) were classified as subgroup B. B strains predominated over A in 1983 -1984 and 1984 . From 1985 to 1990, 284 respiratory syncytial virus field strains were reisolated from frozen materials; 115 (40.5%) were typed as subgroup A and 169 (59.5%) were typed as subgroup B. In -1987B. In -1989, both subgroups were present in almost equal numbers; subgroup A (88.3%) predominated in 1987-1988, and subgroup B (84.5%) predominated in 1989-1990. In conclusion, both subgroups occur together each year, and one subgroup rarely predominates, e.g., subgroup A in 1987-1988 and subgroup B in 1983-1984 and 1989-1990. Therefore, there is a gradual change of the predominant subgroup into another over a period of about 5 years; the relative frequency of subgroup A strains increased from 1983 to 1988, whereas the percentage of subgroup B decreased during the same period.
Winter outbreaks of respiratory syncytial virus (RSV) infections are the cause of serious acute lower respiratory disease in infants (5) . Two major groups of RSV strains with antigenic differences on the N, F, and G proteins have been identified with panels of monoclonal antibodies (MAbs): subgroup A, represented by the Long strain, and subgroup B, represented by the 18537 strain (1, 3, 6, 9, 13) . Several surveys of the prevalence of the RSV subgroups have been published (8, 11, 12, 18, 19) . This study compares the results of those studies with the results obtained in Caen, Normandy, France, during winter epidemics of 1982-1983 through 1989-1990 .
The patients were infants from southern Normandy hospitalized with acute lower respiratory tract infection, bronchiolitis, or pneumonia in the University Hospital of Caen. Most of the children were less than 1 year old, and 50% were under 3 months of age. Viral diagnosis was made on nasal secretions by a fluorescence antibody test and isolation in cell culture. Nasal aspirates were collected by hospital staff nurses; transported to the Virus Laboratory, usually within 3 h; and resuspended in 5 ml of transport medium. Sample suspensions (2 ml) were used for the fluorescence antibody test. The cells were separated by centrifugation, washed in phosphate-buffered saline, deposited on microscope slides, and fixed in acetone. The test used either the bovine polyclonal antibody ( subgroup A in 1983-1984 and 1984-1985 , and the proportion of subgroup A to subgroup B was 2.5:1 (Fig. 1) . Through the five following winter epidemics, i.e., 1985-1986, 1986-1987, 1987-1988, 1988-1989, and 1989-1990 (Fig. 1) . During three outbreaks, 1985-1986, 1986-1987, and 1988-1989 In Caen, the peak of each outbreak occurs regularly in December or January. This RSV epidemic does not tend to follow the pattern first described in Washington, D.C. (10), with a peak occurrence alternating early and late in successive years, and is more similar to the one observed in northeast England (17) . The subgroup A and B strains from the eight annual outbreaks have reacted in a consistent manner with the five MAbs used in this study. No intermediate or indeterminate strains were isolated, supporting the concept that the two subgroups of RSV have been antigenically stable for over at least 25 years (11) (12) (13) . Recently, by using other MAbs, subgroup A strains of RSV have been classified into four patterns: Long-like, A2-like, Bernett-like, and "Massachusetts (M)/85-like"; the last is the predominant strain in four epidemics from 1983 to 1987 (8) . Two major variants of subgroup B strains have also been differentiated (14) .
The comparison of our results with previous studies of RSV subgroup prevalence in Huntington, W.Va. (12), Boston, Mass. (8), St. Louis, Mo. (18), and Sapporo, Japan (19) , indicates that temporal distribution of the two subgroups of RSV is not worldwide and varies in geographic localization, from North America to Asia. Among the five epidemics that were studied in the United States from 1981 to 1986, subgroup A strains predominated in 1981-1982, 1982-1983, and 1985-1986 , in Huntington as well as in St. Louis or in Boston, and only in the first two places during winter 1983-1984. A different pattern was reported in Sapporo: the strains of the 1982-1983, 1984-1985, and 1985-1986 epidemics were predominantly subgroup B strains. In Caen, France, subgroup B of RSV also predominated during the winters of 1983-1984, 1984-1985, and 1985-1986. The major antigenic differences between the two subgroups A and B of RSV are linked to the F and G glycoproteins that play a major role in the acquisition of immunity. The weak immunogenicity of RSV and the progressive immunization against a subgroup after several epidemics of this virus can exclude one strain and favor the spread of the other to occupy an almost exclusive place (7, 8) . This pattern was observed in Caen, where subgroup B strains decreased slowly from 1983 to 1988 whereas subgroup A strains increased progressively in the same time. As the clinical illness associated with RSV is most common between 2 and 4 months of age, and as a new repository of susceptible infants will be available for each annual epidemic, then children older than 1 year must be important for allowing epidemic circulation of the subgroups of RSV and for the gradual change of the predominant subgroup.
RSV is a major cause of bronchiolitis and pneumonia during the first year of life. Mufson et al. (12) reported that clinical characteristics of the disease are different between subgroups A and B of RSV because fewer children develop bronchiolitis in subgroup B infections than in A infections. Monto et al. (11) observed no differences in illness characteristics between the subgroups. The rate of hospitalization of infants for RSV disease is estimated at between 1 in 100 and 1 in 200 (4, 10) . Our study and most of those on the 
